ACHP applauds Congress for passing the Inflation Reduction Act, which will lower drug costs and protect access to ACA exchange coverage.
Drug Pricing
Securing Affordable Treatments for All Americans
Left unchecked, the pharmaceutical industry continues to set exorbitant drug prices and hinder competition in the marketplace. ACHP advocates for policies that promote reasonable prescription drug prices and ensure a sustainable health care system that works for patients and health plans alike. ACHP is dedicated to cracking down on anticompetitive practices, spurring development of generic and biosimilar treatments and increasing transparency around price setting.
To the Point
-
12/22/2021
BLOG — Aduhelm’s Price Cut Misses the Mark
Besides being outrageously priced, Aduhelm is an unproven, potentially dangerous drug—a drug Medicare simply should not cover. -
08/25/2021
POLICY POSITIONING — Curbing High Drug Costs
ACHP's bipartisan policy recommendations will help hold drug makers accountable and curb exorbitantly high drug costs. -
03/06/2020
FACT SHEET — Support Legislation to Reduce Drug Prices
Legislation can help check drug makers ability to hike prices and inject more competition into the market — helping lower prices for all. -
04/08/2019
INFOGRAPHIC — A Unique Approach: Transparent PBMs
ACHP member health plans run fully transparent, fee-based PBMs that keep drug costs in check. -
10/05/2018
INFOGRAPHIC — Biosimilars: An Antidote For High Prices
Millions struggle to pay high drug prices, forcing them to choose either medication or other expenses. Our infographic explains how “biosimilars” can help.
Deep Dive
-
12/23/2021
PODCAST—Build Back Better, ACA and Drug Pricing on Kaiser Health News’ What the Health?
ACHP's Ceci Connolly discusses the Build Back Better Act, ACA enrollment, drug pricing and more on KHN's What the Health? podcast. -
10/21/2021
LETTER — ACHP Urges Lawmakers to Include Vital Health Provisions in Build Back Better Act
ACHP urges lawmakers debating the Build Back Better Act to include important health provisions that will expand access and lower costs. -
09/01/2021
VIDEO — Tackling High-Cost Specialty Drugs and Preserving Patient Centered Innovation (Webinar)
ACHP examines how organizations are managing high-cost specialty drugs to ensure patients get the drugs they need without breaking the bank. -
08/27/2021
ISSUE BRIEF — Lowering Drug Costs through Transparency and Competition
ACHP proposes bold reforms aimed at lowering drug costs by promoting transparency, competition and innovation. -
06/17/2021
OP-ED — Community Health Plans Are Serious: Support Major Federal Action to Reduce Prescription Drug Costs
ACHP backs concrete efforts by the federal government to reign in high drug costs, such as empowering Medicare negotiations.
Resource Library Search
INFOGRAPHIC — Protect Affordable Individual Coverage and Care
This infographic breaks down how extending enhanced subsidies protects affordable individual coverage and care.
BLOG — Enhanced ACA Subsidies Provide Respite in Sea of Rising Prices
Enhanced ACA subsidies have lowered costs and expanded access for millions of Americans struggling with other expenses.
LETTER — Letter to Leadership Urging Action on ACA Tax Credits
The Alliance of Community Health Plans urges Congressional leaders to make ACA tax credit enhancements permanent.
INFOGRAPHIC — The Cost of Low-Value Care
30 percent of all health care spending in the United States is on low-value or unnecessary care—wasting billions and harming consumers.
RELEASE — ACHP Applauds Senate Passage of Inflation Reduction Act
In response to the Senate passing the Inflation Reduction Act, ACHP President andRead more
OP-ED — Don’t Let Hospital at Home Shrivel When the Public Health Emergency Ends (STAT News)
In an op-ed for STAT News, ACHP’s Ceci Connolly and Permanente Medicine’s Dr. Steve Parodi explore the power of hospital at home programs.